BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare ...

CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

Novo Nordisk received approval from the U.S. FDA for the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess ...

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Rectify Pharmaceuticals has entered a strategic research and licensing agreement with Boehringer Ingelheim to accelerate the ...

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

Nine leading global pharmaceutical companies announced broad agreements with the Trump administration on Friday to lower the ...

Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...

Symbiosis Pharmaceutical Services, a sterile fill finish contract manufacturing organization (CMO), has manufactured its first 10,000 vial batch at the company’s new facility in Stirling, UK.

Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective immediately.